Frank A. Holler, Director at Xenon Pharmaceuticals Inc. (XENE), sold 9,437 shares at $9.28 ($88K) on 2019-09-18, disclosed to the SEC on 2019-09-18.
Open-market sale of $88k XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.32 | 5,069 | $47K | 53.8% |
| 2 | $9.28 | 4,368 | $41K | 46.2% |
| Total | $9.30 avg | 9,437 | $88K | 100% |
| Filing → |
| XENE | SELL | 2016-12-19 | $236K | — | Filing → |
| XENE | SELL | 2016-08-23 | $183K | — | Filing → |
| XENE | SELL | 2016-08-18 | $274K | — | Filing → |